Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 21;37(3):BSR20170002.
doi: 10.1042/BSR20170002. Print 2017 Jun 30.

Vascular endothelial growth factor modified macrophages transdifferentiate into endothelial-like cells and decrease foam cell formation

Affiliations

Vascular endothelial growth factor modified macrophages transdifferentiate into endothelial-like cells and decrease foam cell formation

Dan Yan et al. Biosci Rep. .

Abstract

Macrophages are largely involved in the whole process of atherosclerosis from an initiation lesion to an advanced lesion. Endothelial disruption is the initial step and macrophage-derived foam cells are the hallmark of atherosclerosis. Promotion of vascular integrity and inhibition of foam cell formation are two important strategies for preventing atherosclerosis. How can we inhibit even the reverse negative role of macrophages in atherosclerosis? The present study was performed to investigate if overexpressing endogenous human vascular endothelial growth factor (VEGF) could facilitate transdifferentiation of macrophages into endothelial-like cells (ELCs) and inhibit foam cell formation. We demonstrated that VEGF-modified macrophages which stably overexpressed human VEGF (hVEGF165) displayed a high capability to alter their phenotype and function into ELCs in vitro Exogenous VEGF could not replace endogenous VEGF to induce the transdifferentiation of macrophages into ELCs in vitro We further showed that VEGF-modified macrophages significantly decreased cytoplasmic lipid accumulation after treatment with oxidized LDL (ox-LDL). Moreover, down-regulation of CD36 expression in these cells was probably one of the mechanisms of reduction in foam cell formation. Our results provided the in vitro proof of VEGF-modified macrophages as atheroprotective therapeutic cells by both promotion of vascular repair and inhibition of foam cell formation.

Keywords: endothelial-like cells; foam cell; macrophages; vascular endothelial growth factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. Effect of stable overexpression of VEGF on macrophages in phenotypic characteristics
(A) Quantitative analysis of mRNA expression of endothelial markers by real-time PCR. mRNA expression of FLK-1, vWF, eNOS, VE-cadherin, and Tie-2 were dramatically increased in hVEGF165-ZsGreen1-RAW264.7 cells compared with untransfected RAW264.7, ZsGreen1-RAW264.7, and exogenous VEGF-treated RAW264.7. Data are normalized to β-actin and presented as fold difference relative to RAW267.4 control. (B) Western blot analysis of endothelial markers expression. Protein expression of FLK-1, vWF, and eNOS were dramatically increased in hVEGF165-ZsGreen1-RAW264.7 cells compared with untransfected RAW264.7, ZsGreen1-RAW264.7, and exogenous VEGF-treated RAW264.7. All images are representatives of three independent experiments each performed in triplicate, and graphs depict the value of mean and S.D. * indicates P<0.01.
Figure 2
Figure 2. Effect of stable overexpression of VEGF on macrophages in tubular networks formation
After 24 h of culture in Matrigel, hVEGF165-ZsGreen1-RAW264.7 formed tubular structures. But no similar structure was detected in untransfected RAW264.7, ZsGreen1-RAW264.7, or exogenous VEGF-treated RAW264.7. Scale bars =100 μm. All images are representatives of three independent experiments.
Figure 3
Figure 3. VEGF165 secretion level in supernatant after 72 h serum-free culture by ELISA
(A) hVEGF165 production increased dramatically in hVEGF165-ZsGreen1-RAW264.7, but could not be detected in untransfected RAW264.7 and control transfected ZsGreen1-RAW264.7 (P<0.01). (B) Mouse VEGF165 secretion level in VEGF165-ZsGreen1-RAW264.7 is much higher than that in untransfected and control transfected groups. Data represent mean ± S.D. of three independent experiments each performed in triplicate. * indicates P<0.01.
Figure 4
Figure 4. Foam cell formation assay
(A) Representative images of foam cell formation assay. Untransfected RAW264.7, ZsGreen1-RAW264.7, and hVEGF165-ZsGreen1-RAW264.7 were treated with 100 μg/ml ox-LDL for 24 h. After fixation and staining with Oil Red O, the cells were observed by light microscopy. Cytoplasmic lipid droplets accumulated in RAW264.7 or ZsGreen1-RAW264.7, but hVEGF165-ZsGreen1-RAW264.7 cells showed significantly decreased lipid accumulation. Scale bars =50 μm. (B) Quantitative analysis of lipid accumulation in cells. The cells stained with Oil Red O were treated with 1 ml 60% isopropanol for 1 h to redissolve the oil red O and absorbance was detected at 518 nm through a spectrophotometer. The absorbance of oil red O was significantly decreased in hVEGF165-ZsGreen1-RAW264.7 compared with RAW264.7 or ZsGreen1-RAW264.7 cells. Data represent mean ± S.D. of three independent experiments each performed in triplicate. * indicates P<0.01.
Figure 5
Figure 5. Stable overexpression of VEGF down-regulates expression of CD36 in macrophages
(A) Quantitative analysis of mRNA expression of CD36 by qRT-PCR. After treating with 100 μg/ml ox-LDL for 24 h, mRNA expression of CD36 were significantly decreased in hVEGF165-ZsGreen1-RAW264.7 cells compared with that in RAW264.7 and ZsGreen1-RAW264.7. (B) Western blot analysis for endothelial cell markers expression. Protein expression of CD36 was significantly decreased in hVEGF165-ZsGreen1-RAW264.7 cells compared with RAW264.7 and ZsGreen1-RAW264.7. Data represent mean ± S.D. of three independent experiments each performed in triplicate. #indicates P<0.05.

Similar articles

Cited by

References

    1. Thompson R.C., Allam A.H., Lombardi G.P., Wann L.S., Sutherland M.L. et al. (2013) Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet 381, 1211–1222 - PubMed
    1. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B. et al. (2012) Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 125, e2–e220 - PMC - PubMed
    1. Liao J.K. (2013) Linking endothelial dysfunction with endothelial cell activation. J. Clin. Invest. 123, 540–541 - PMC - PubMed
    1. Flammer A.J., Anderson T., Celermajer D.S., Creager M.A., Deanfield J., Ganz P. et al. (2012) The assessment of endothelial function: from research into clinical practice. Circulation 126, 753–767 - PMC - PubMed
    1. Gimbrone M.A. Jr and Garcia-Cardena G. (2016) Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res. 118, 620–636 - PMC - PubMed

MeSH terms

LinkOut - more resources